학술논문

Efficacy and safety of upadacitinib for 16-week extended induction and 52-week maintenance therapy in patients with moderately to severely active ulcerative colitis
Document Type
Article
Source
In: Alimentary Pharmacology and Therapeutics. (Alimentary Pharmacology and Therapeutics, February 2024, 59(3):393-408)
Subject
Language
English
ISSN
13652036
02692813